Vimarsana
Biggest News Aggregation in the World

Page 28 - Eu Press News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Eu Press. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Eu Press Today - Breaking & Trending Today

Biotalys Strengthens Relationship with Investors via Private Placement of New Shares for €7 million - Vimarsana News

Biotalys Strengthens Relationship with Investors via Private Placement of New Shares for €7 million

Ghent, BELGIUM, June 07, 2023 -- Press release - Regulated information - Inside Information Biotalys NV , an Agricultural Technology company developing protein-based biocontrol solutions for... | June 7, 2023

Nokia Corporation: Repurchase of own shares on 07.06.2023 - Vimarsana News

Nokia Corporation: Repurchase of own shares on 07.06.2023

Nokia CorporationStock Exchange Release7 June 2023 at 21:00 EEST Nokia Corporation: Repurchase of own shares on 07.06.2023 Espoo, Finland – On 7 June 2023 Nokia Corporation has acquired its... | June 7, 2023

Zealand Pharma to Participate in Upcoming Healthcare Conferences - Vimarsana News

Zealand Pharma to Participate in Upcoming Healthcare Conferences

Press release – No. 4 / 2023 Zealand Pharma to Participate in Upcoming Healthcare Conferences Copenhagen, Denmark, June 6, 2023 – Zealand Pharma A/S , a biotechnology... | June 6, 2023

Form 8.3 - FireAngel Safety Technology Group Plc - Vimarsana News

Form 8.3 - FireAngel Safety Technology Group Plc

Downing LLPLEI: 213800G3X76VBG9SB5046 June 2023Form 8.3 re. FireAngel Safety Technology Group Plc PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT... | June 6, 2023

Tiziana Life Sciences Announces Reduction in Microglial Activation in a Total of 5 Out of 6 Intranasal Foralumab Expanded Access Patients with Non-Active Secondary Progressive Multiple Sclerosis - Vimarsana News

Tiziana Life Sciences Announces Reduction in Microglial Activation in a Total of 5 Out of 6 Intranasal Foralumab Expanded Access Patients with Non-Active Secondary Progressive Multiple Sclerosis

Results confirm positive signal previously reported in the first two Expanded Access patients who both subsequently demonstrated clinical improvementsPhase 2a trial in na-SPMS on track to begin in Q3... | June 5, 2023